Founded
Address
CHL Medical Partners
1055 Washington Boulevard
6th Floor
Stamford, CT 06901
United States
Phone
Email
Website
Recent investment activity
KANDO id: 41535
Company type
Venture capital firm focused on early-stage healthcare sectors.Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 51 - 71 of 71| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Raytel Medical | Heart pacemaker monitoring service and outpatient MRI service company. | N/A | |||
|
|
Resolvyx Pharmaceuticals Inc | A biopharmaceutical company developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. | N/A | |||
|
|
Revivant Corp | Medical device company that provides alternative approaches to cardiopulmonary resuscitation. | Series B | |||
|
|
RxCentric Inc | Pharmaceutical marketing and detailing company via the internet. | N/A | |||
|
|
SemperCare Inc | N/A | ||||
|
|
Threshold Pharmaceuticals Inc | N/A | ||||
|
|
Valeritas Inc | N/A | ||||
|
|
Vascular Pathways Inc | N/A | ||||
|
|
VaxInnate Corp | N/A | ||||
|
|
VaxInnate Inc | A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. | Series D | |||
|
|
VaxInnate Inc | A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. | Series C | |||
|
|
Vertos Medical Inc | Series D | ||||
|
|
American Renal Associates Holdings Inc | Developer, owner and operator of outpatient kidney dialysis facilities. | N/A | |||
|
|
Amicus Therapeutics Inc | N/A Initial investment | ||||
|
|
BioRelix Inc | Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. | Series A Follow-on investment led the round Ronald W Lennox | |||
|
|
BioRelix Inc | Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. | Seed Initial investment | |||
|
|
Cell Therapeutics Inc | Biotherapeutics for cancer treatment. | N/A | |||
|
|
Neurogen Corp | N/A | ||||
|
|
Spine Wave Inc | Medical device company focused on degenerative disc disease, vertebral compression fractures, and nucleus replacement. | Series D | |||
|
|
Spine Wave Inc | Medical device company focused on degenerative disc disease, vertebral compression fractures, and nucleus replacement. | Series C | |||
|
|
Valentis | Biopharmaceuticals company in the fields of cardiovascular disease, oncology, and infectious diseases. | N/A |